Perrigo | Pasivo Circulante



Current Liabilities Cambio Fecha
AbbVie USD 38.75B 4.31B 2024-12
Abbott USD 14.16B 745M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Dr.Reddys Laboratories INR 131.95B 2.74B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
J&J USD 50.32B 1.44B 2024-12
Merck USD 28.42B 1.17B 2024-12
Nestle CHF 42.86B 3.16B 2024-12
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Prestige Brands USD 102.54M 4.36M 2024-12
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi 30.03B 5.82B 2024-06
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Perrigo Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.